WST vs MSFT: Which Stock is Better?
Side-by-side comparison of West Pharmaceutical Services Inc and Microsoft Corp in 2026
WST
West Pharmaceutical Services Inc
$254.34
MSFT
Microsoft Corp
$397.23
Key Metrics Comparison
| Metric | WST | MSFT | Winner |
|---|---|---|---|
| Market Cap | $18.32B | N/A | WST |
| P/E Ratio | 37.46 | 24.58 | MSFT |
| EPS (TTM) | $6.79 | $15.98 | MSFT |
| Revenue Growth | 0.1% | 0.2% | MSFT |
| Gross Margin | 35.9% | 68.6% | MSFT |
Analyze WST
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is WST or MSFT a better investment?
Comparing WST and MSFT: West Pharmaceutical Services Inc has a market cap of $18.32B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between WST and MSFT?
WST (West Pharmaceutical Services Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: WST or MSFT?
Based on P/E ratios, MSFT trades at a lower multiple (24.6x vs 37.5x).
Which is growing faster: WST or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.1% for WST.
Which company is more profitable: WST or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 35.9% for WST.
Which is the larger company: WST or MSFT?
West Pharmaceutical Services Inc (WST) is larger with a market cap of $18.32B compared to N/A for MSFT.
Should I buy WST or MSFT in 2026?
Both WST and MSFT have investment merit. WST trades at $254.34 while MSFT trades at $397.23. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between WST and MSFT stock?
Key differences: Market Cap ($18.32B vs N/A), P/E Ratio (37.5x vs 24.6x), Revenue Growth (0.1% vs 0.2%), Gross Margin (35.9% vs 68.6%).